DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Isometheptene

Isometheptene

  • Educational Commentary – Testing for Amphetamines and Related Compounds

    Educational Commentary – Testing for Amphetamines and Related Compounds

  • Drug Formulary Medi-Cal/Healthy Families Drug Formulary • 2014

    Drug Formulary Medi-Cal/Healthy Families Drug Formulary • 2014

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Review Memorandum

    Review Memorandum

  • Acetaminophen, Isometheptene, and Dichloralphenazone

    Acetaminophen, Isometheptene, and Dichloralphenazone

  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

    Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

  • PQA Measure Specifications ______

    PQA Measure Specifications ______

  • Urine Drug Testing Methods3-5 Urine Drug Testing Specimen Validity3-4

    Urine Drug Testing Methods3-5 Urine Drug Testing Specimen Validity3-4

  • Appendix-2Final.Pdf 663.7 KB

    Appendix-2Final.Pdf 663.7 KB

  • Drug and Medication Classification Schedule

    Drug and Medication Classification Schedule

  • No 1223/2009 of the EUROPEAN PARLIAMENT and of the COUNCIL of 30 November 2009 on Cosmetic Products (Recast) (Text with EEA Relevance) (OJ L 342, 22.12.2009, P

    No 1223/2009 of the EUROPEAN PARLIAMENT and of the COUNCIL of 30 November 2009 on Cosmetic Products (Recast) (Text with EEA Relevance) (OJ L 342, 22.12.2009, P

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Pharmacology of Stimulants Prohibited by the World Anti-Doping Agency (WADA)

    Pharmacology of Stimulants Prohibited by the World Anti-Doping Agency (WADA)

  • 2019 Prohibited List

    2019 Prohibited List

  • (12) Patent Application Publication (10) Pub. No.: US 2014/0212486A1 LEDERMAN Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2014/0212486A1 LEDERMAN Et Al

  • European Patent Office

    European Patent Office

  • Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services

    Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services

  • I (Acts Whose Publication Is Obligatory) COMMISSION

    I (Acts Whose Publication Is Obligatory) COMMISSION

Top View
  • WO 2010/015029 Al
  • Drug/Substance Trade Name(S)
  • Urine Drug Testing: Current Recommendations and Best Practices
  • Chapter 25. Controlled Substances, Drugs, Devices, and Cosmetics
  • Prohibited List 2021
  • Pain Management Opioid Safety
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Marrakesh Agreement Establishing the World Trade Organization
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
  • Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agent
  • Examples of Prohibited and Permitted Substances And
  • 2302 Index Prefixes Such As Α-, Β-, O-, M-, P-, D-, L-, N-, O-, R-, S
  • Pharmaabkommen A1 E
  • Pdf 127.33 Kb
  • US 9649297 B2 Gait No. TA 2009. O O Ch 7. Dhikav, Medical Hypotheses
  • (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
  • EMIT Drugs-Of-Abuse Urine Assays Cross-Reactivity List


© 2024 Docslib.org    Feedback